Abstract:Background: Among head and neck squamous cell carcinomas (HNSCCs), hypopharyngeal squamous cell carcinoma (HPSCC) has the worst prognosis. Iron metabolism, which plays a crucial role in tumor progression, is mainly regulated by alterations to genes and post-transcriptional processes. The recent discovery of the N6-methyladenosine (m(6)A) modification has expanded the realm of previously undiscovered post-transcriptional gene regulation mechanisms in eukaryotes. Many studies have demonstrated that m(6)A methylation represents a distinct layer of epigenetic deregulation in carcinogenesis and tumor proliferation. However, the status of m(6)A modification and iron metabolism in HPSCC remains unknown. Methods: Bioinformatics analysis, sample analysis, and transcriptome sequencing were performed to evaluate the correlation between m(6)A modification and iron metabolism. Iron metabolic and cell biological analyses were conducted to evaluate the effect of the m(6)A reader YTHDF1 on HPSCC proliferation and iron metabolism. Transcriptome-wide m(6)A-seq and RIP-seq data were mapped to explore the molecular mechanism of YTHDF1 function in HPSCC. Results: YTHDF1 was found to be closely associated with ferritin levels and intratumoral iron concentrations in HPSCC patients at Sir Run Run Shaw Hospital. YTHDF1 induced-HPSCC tumorigenesis depends on iron metabolism in vivo in vitro. Mechanistically, YTHDF1 methyltransferase domain interacts with the 3'UTR and 5'UTR of TRFC mRNA, then further positively regulates translation of m(6)A-modified TFRC mRNA. Gain-of-function and loss-of-function analyses validated the finding showing that TFRC is a crucial target gene for YTHDF1-mediated increases in iron metabolism. Conclusion: YTHDF1 enhanced TFRC expression in HPSCC through an m(6)A-dependent mechanism. From a therapeutic perspective, targeting YTHDF1 and TFRC-mediated iron metabolism may be a promising strategy for HPSCC.

The YTHDF proteins display distinct cellular functions on m 6 A-modified RNA

The Roles and Mechanisms of YTH Domain-Containing Proteins in Cancer Development and Progression.

Understanding the redundant functions of the m6A-binding YTHDF proteins

YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA

M6a-Binding Proteins: the Emerging Crucial Performers in Epigenetics

N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms

Linking the YTH Domain to Cancer: the Importance of YTH Family Proteins in Epigenetics

The biological function of the N6-Methyladenosine reader YTHDC2 and its role in diseases

N 6 -methyladenosine-dependent regulation of messenger RNA stability

O-GlcNAcylation determines the translational regulation and phase separation of YTHDF proteins

YTHDF2 Binds to 5-Methylcytosine in RNA and Modulates the Maturation of Ribosomal RNA

Binding to M6a RNA Promotes YTHDF2-mediated Phase Separation

N6-Methyladenosine RNA-Binding Protein YTHDF1 in Gastrointestinal Cancers: Function, Molecular Mechanism and Clinical Implication

Novel insights into roles of N6-methyladenosine reader YTHDF2 in cancer progression

YTHDF2 destabilizes m 6 A-containing RNA through direct recruitment of the CCR4–NOT deadenylase complex

Biological functions of the m6A reader YTHDF2 and its role in central nervous system disorders

N6-methyladenosine modifications: interactions with novel RNA-binding proteins and roles in signal transduction.

YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4–NOT deadenylase complex

The function and clinical implication of YTHDF1 in the human system development and cancer

YTHDF1-enhanced iron metabolism depends on TFRC m 6 A methylation.

Ythdc2 is an N6-methyladenosine binding protein that regulates mammalian spermatogenesis